Ramzi Abdulrahman

The University of Texas Southwestern Medical Center

Papers

1

Total Citations

7

H-Index

1

About

Ramzi Abdulrahman is a radiation oncologist whose work bridges the gap between advanced radiotherapy techniques and clinical outcomes, particularly in head and neck cancers. His research focuses on hypofractionated stereotactic body radiotherapy (SBRT) for early-stage glottic laryngeal cancer, a novel approach that delivers precise, high-dose radiation in fewer sessions to improve patient convenience and tumor control. His most-cited paper, "Phantom-to-clinic development of hypofractionated stereotactic body radiotherapy for early-stage glottic laryngeal cancer" (2017, 7 citations), exemplifies his translational impact, detailing the journey from dosimetric phantom studies to clinical implementation. This work has contributed to safer, more effective treatment protocols, reducing toxicity while maintaining efficacy. Abdulrahman’s contributions are notable for their focus on optimizing radiotherapy delivery, with potential to expand SBRT applications in laryngeal cancer—a field where organ preservation is critical. His research, though early in citation accumulation, underscores a commitment to innovation in precision oncology, making him a key figure in advancing non-surgical options for head and neck malignancies.

Research Focus

Key Achievements

1
H-Index
1
Papers
7
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Phantom-to-clinic development of hypofractionated stereotactic body radiotherapy for early-stage glottic laryngeal cancer
7 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: The University of Texas Southwestern Medical Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago